Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 96 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cervical Intraepithelial Clear all

Conditions: Oral Cancer
Interventions: Erlotinib, Placebo; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2018
U.S. locations: 4
States / cities: Atlanta, Georgia • Chicago, Illinois • New York, New York + 1 more

Conditions: Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL
Interventions: VGX-3100, Matched Placebo, CELLECTRA™-5PSP; Biological · Device
Lead sponsor: Inovio Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 27
States / cities: Tucson, Arizona • Danbury, Connecticut • Newark, Delaware + 24 more

Conditions: CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
Interventions: Artesunate vaginal insert, Placebo vaginal insert; Drug
Lead sponsor: Frantz Viral Therapeutics, LLC; Industry
Eligibility: 25 Years to 100 Years · Female only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 7
States / cities: Fort Myers, Florida • Ann Arbor, Michigan • Cleveland, Ohio + 2 more

Conditions: Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain)
Interventions: Artesunate Suppositories; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: Baltimore, Maryland • Towson, Maryland

Conditions: Human Papillomavirus, High-Grade Squamous Intraepithelial Lesions
Interventions: TVGV-1, GPI-0100, Placebo; Biological
Lead sponsor: THEVAX Genetics Vaccine; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 11
States / cities: Tucson, Arizona • Lakewood, Colorado • Port Orange, Florida + 8 more

Conditions: Cervix Cancer, Cervix Lesion
Interventions: Liger Medical Thermocoagulator; Device
Lead sponsor: PATH; Other
Eligibility: 30 Years to 49 Years · Female only
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Oral Cavity Carcinoma, Oral Intraepithelial Neoplasia
Interventions: Laboratory Biomarker Analysis, Patient Observation, Pembrolizumab; Other · Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cervical Intraepithelial Neoplasia, Invasive Cervical Cancer
Interventions: Fenofibrate, Cervical Conization, Hysterectomy, Chemoradiation; Drug · Procedure · Radiation
Lead sponsor: Lindsay Ferguson, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: High Grade Cervical Intraepithelial Neoplasia
Interventions: DySIS; Device
Lead sponsor: DySIS Medical Inc.; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 7,555 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 46
States / cities: Scottsdale, Arizona • Gainesville, Florida • Jacksonville, Florida + 39 more

Conditions: HIV Infections, Cervix, Dysplasia
Interventions: Isotretinoin; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2001
U.S. locations: 37
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 25 more

Conditions: Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection, Serology, Cervical Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Oral Cavity Infection
Interventions: Human papillomavirus 9-valent vaccine, recombinant, human papillomavirus vaccine, recombinant; Biological
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Cervical Intraepithelial Neoplasia
Interventions: PepCan, Candin®; Biological
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Cervical Cancer, Precancerous Condition
Interventions: HspE7; Biological
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Cervical Intraepithelial Neoplasia
Interventions: Large loop electrosurgical excision; Procedure
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1999
U.S. locations: 1
States / cities: Orange, California

Conditions: Cervical Intraepithelial Neoplasia, Human Papillomavirus
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 26 Years to 65 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cervical Cancer, Cervical Intraepithelial, Neoplasia, CIN
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 3,013 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2020
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cervical Cancer
Interventions: Colposcopy; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Cervical Cancer, Precancerous Condition
Interventions: Multispectral Digital Colposcope (MDC); Device
Lead sponsor: British Columbia Cancer Agency; Other
Eligibility: 18 Years and older · Female only
Enrollment: 551 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Brooklyn, New York • El Paso, Texas

Conditions: High-grade Cervical Intraepithelial Neoplasia
Interventions: Focal LEEP; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 1, Human Papilloma Virus Infection
Interventions: placebo, defined green tea catechin extract, laboratory biomarker analysis; Drug · Dietary Supplement · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cervical Intraepithelial Neoplasia Grade 2/3
Interventions: FRD, Cytology, HPV testing, Colposcopy, ECC, Biospy; Combination Product · Other · Procedure
Lead sponsor: GY Highland Biotech LLC; Industry
Eligibility: 20 Years to 60 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Cervical Dysplasia
Interventions: di indolylmethane (DIM), Red rice bran; Drug · Dietary Supplement
Lead sponsor: New York Presbyterian Hospital; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: HPV16 Positive, Cervical Intraepithelial Neoplasia (CIN 2/3)
Interventions: DNA vaccination, Gene gun vaccine, intramuscular vaccination, intra-lesional vaccine administration, therapeutic resection of the lesion, imiquimod; Biological · Device · Procedure + 1 more
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 3
States / cities: Birmingham, Alabama • Baltimore, Maryland

Conditions: Atypical Squamous Cells of Undetermined Significance, Cervical Cancer, High-grade Squamous Intraepithelial Lesion, Low-grade Squamous Intraepithelial Lesion
Interventions: HspE7, placebo, laboratory biomarker analysis; Biological · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Orange, California

Search by objective public record fields.

Erlotinib Prevention of Oral Cancer (EPOC)

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Honduras Liger Thermocoagulator Study

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

IMproved PRactice Outcomes and Value Excellence in Colposcopy

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia

Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit

A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening

Cervical Cancer Early Endpoints and Determinants

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection

An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection

Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells